Learn more at LeadIQ.com

Insights

Gene Therapy Innovations Decibel Therapeutics focuses on gene therapy advancements for treating hearing and balance disorders, offering potential collaboration opportunities with pharmaceutical companies seeking innovative solutions in the biotechnology space.

Mergers and Acquisitions Decibel Therapeutics has engaged in mergers and acquisitions activities, such as the recent merger with Regeneron, indicating potential interest in expanding capabilities or acquiring complementary technologies from other organizations in the industry.

Clinical Trial Launches With the launch of the CHORD gene therapy clinical trial, Decibel presents opportunities for partnerships with healthcare institutions and research organizations interested in participating in cutting-edge clinical studies for hearing and balance disorders.

Strategic Partnerships Decibel Therapeutics has formed strategic partnerships with companies like Regeneron, showcasing potential avenues for collaboration with businesses looking to leverage joint expertise and resources in developing novel treatments for genetic hearing loss.

Board of Directors Expansion The appointment of Kevin F. McLaughlin to the Board of Directors signals growth and potential business development opportunities for Decibel Therapeutics, presenting possibilities for networking with industry leaders and accessing valuable insights for future sales endeavors.

Similar companies to Decibel Therapeutics

Decibel Therapeutics Tech Stack

Decibel Therapeutics uses 8 technology products and services including Google Analytics, WordPress, Drupal, and more. Explore Decibel Therapeutics's tech stack below.

Google Analytics
Analytics
WordPress
Content Management System
Drupal
Content Management System
MySQL
Database
Font Awesome
Font Scripts
Google Font API
Font Scripts
WP Featherlight
Web Platform Extensions
Nginx
Web Servers

Media & News

Decibel Therapeutics's Email Address Formats

Decibel Therapeutics uses at least 1 format(s):

Decibel Therapeutics Email Formats	Example	Percentage
FLast@decibeltx.com	JDoe@decibeltx.com	97%
F.Last@decibeltx.com	J.Doe@decibeltx.com	1%
FMiddleLast@decibeltx.com	JMichaelDoe@decibeltx.com	1%
LFirst@decibeltx.com	DJohn@decibeltx.com	1%

Frequently Asked Questions

Where is Decibel Therapeutics's headquarters located?

Decibel Therapeutics's main headquarters is located at 1325 Boylston Street Suite 500 Boston, MA 02215 US. The company has employees across 2 continents, including North AmericaAsia.

What is Decibel Therapeutics's phone number?

You can contact Decibel Therapeutics's main corporate office by phone at

+1-617-370-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Decibel Therapeutics's stock symbol?

Decibel Therapeutics is a publicly traded company; the company's stock symbol is DBTX.

What is Decibel Therapeutics's official website and social media links?

Decibel Therapeutics's official website is decibeltx.com and has social profiles on LinkedIn.

How much revenue does Decibel Therapeutics generate?

As of October 2024, Decibel Therapeutics's annual revenue reached $35M.

What is Decibel Therapeutics's SIC code NAICS code?

Decibel Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Decibel Therapeutics have currently?

As of October 2024, Decibel Therapeutics has approximately 51 employees across 2 continents, including North AmericaAsia. Key team members include VP Pharmacology: A. S.Vice President Quality Assurance: E. M.Vice President, Finance: J. S.. Explore Decibel Therapeutics's employee directory with LeadIQ.

What industry does Decibel Therapeutics belong to?

Decibel Therapeutics operates in the Biotechnology Research industry.

What technology does Decibel Therapeutics use?

Decibel Therapeutics's tech stack includes Google AnalyticsWordPressDrupalMySQLFont AwesomeGoogle Font APIWP FeatherlightNginx.

What is Decibel Therapeutics's email format?

Decibel Therapeutics's email format typically follows the pattern of . Find more Decibel Therapeutics email formats with LeadIQ.

How much funding has Decibel Therapeutics raised to date?

As of October 2024, Decibel Therapeutics has raised $82M in funding. The last funding round occurred on Nov 09, 2020 for $82M.

Decibel Therapeutics

Decibel Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine. Decibel has built a proprietary platform that integrates single-cell genomics and bioinformatic analyses, precision gene therapy technologies and expertise in inner ear biology. Decibel is leveraging its platform to advance gene therapies designed to selectively replace genes for the treatment of congenital, monogenic hearing loss and to regenerate inner ear hair cells for the treatment of acquired hearing and balance disorders. Decibel’s pipeline, including its lead gene therapy program, DB-OTO, to treat congenital, monogenic hearing loss, is designed to deliver on our vision of building a world of connection for people with hearing and balance disorders.

Guidelines: https://bit.ly/3IzmNvU

Company Overview

Headquarters: 1325 Boylston Street Suite 500 Boston, MA 02215 US
Phone number: ✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-617-370-****
Website: decibeltx.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: DBTX
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 51-200

Media & News

Funding & Financials

$82M
Decibel Therapeutics has raised a total of $82M of funding over 5 rounds. Their latest funding round was raised on Nov 09, 2020 in the amount of $82M.
$10M$50M
Decibel Therapeutics's revenue is in the range of $10M$50M

Funding & Financials

$82M
Decibel Therapeutics has raised a total of $82M of funding over 5 rounds. Their latest funding round was raised on Nov 09, 2020 in the amount of $82M.
$10M$50M
Decibel Therapeutics's revenue is in the range of $10M$50M

Company Leadership

A. S.
VP Pharmacology
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. M.
Vice President Quality Assurance
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. S.
Vice President, Finance
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. P.
Senior Director And Head Of Genomics And Computational Biology
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. P.
Senior Director, Head Of Clinical Operations
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

E. C.
Vice President, Operations
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. K.
Vice President, Clinical Development Operations
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. M.
Vice President Quality Assurance
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. P.
Vice President, Head Of Chemistry
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. C. S.
Vice President, Legal
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Decibel Therapeutics and Millions of Other Companies
Sign up for full access to Decibel Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.